The ROI Juan A. del Regato Fund supports webinars for residents through a partnership with ARRO and ASTRO. The on demand webinar replays are free to all in the radiation oncology community.
The dividends of your gift to ROI today are better outcomes for your
patients and the development of the research leaders of tomorrow.
The Radiation Oncology Institute (ROI) is a nonprofit foundation working to heighten the critical role of radiation therapy in the treatment of cancer through research and education. Founded in 2006 by the American Society for Radiation Oncology (ASTRO), the ROI is an affiliated 501(c)(3) organization established to support research and education about the life-saving and quality-of-life benefits of radiation therapy.
With the support of our generous donors, the ROI has funded $3.7 million in research in priority topic areas to improve outcomes for cancer patients and advance the field of radiation oncology.
Hear from each of the new Biomarkers for Radiation
Oncology Award winners about why the ROI funding is
important to their research and how you can help support
the ROI by participating in the 5K Race for Cancer Research
at the ASTRO Annual Meeting in Chicago.
Learn about the exciting new research grants that will be led by Hesham Elhalawani, MD, MSc; David Miyamoto, MD, PhD; Sonal Noticewala, MD, MAS; and Co-PIs Nina Sanford, MD, and Wen Jiang, MD, PhD.
Dr. Luh is a radiation oncologist at St. Joseph Hospital in Eureka, California. He supports the ROI as a member of the ROI Founders' Circle and President's Circle because it gives radiation oncology investigators a lifeline to initiate and continue the research that defines the important role radiation oncology plays in cancer treatment. Dr. Luh also serves as the Vice-Chair of the ROI Development Committee.